Medical Care

Global Cystic Fibrosis Therapeutics Market Research Report 2025

The global market for Cystic Fibrosis Therapeutics was valued at US$ 5930 million in the year 2024 and is projected to reach a revised size of US$ 14220 million by 2031, growing at a CAGR of 13.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis Therapeutics.
The Cystic Fibrosis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cystic Fibrosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cystic Fibrosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Vertex Pharmaceuticals
F. Hoffmann-La Roche
AbbVie
Gilead Sciences
Novartis
AstraZeneca
Bayer
Celtaxsys
Pharmaxis
ProQR Therapeutics
PTC Therapeutics
Alcresta Therapeutics
Insmed Incorporated
Savara
Cyclacel Pharmaceuticals
Vectura
Allergan
Segment by Type
CFTR
Mucolytics
PERT
Anti-infectives
Bronchodilators
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CFTR
1.2.3 Mucolytics
1.2.4 PERT
1.2.5 Anti-infectives
1.2.6 Bronchodilators
1.3 Market by Application
1.3.1 Global Cystic Fibrosis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cystic Fibrosis Therapeutics Market Perspective (2020-2031)
2.2 Global Cystic Fibrosis Therapeutics Growth Trends by Region
2.2.1 Global Cystic Fibrosis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cystic Fibrosis Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Cystic Fibrosis Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Cystic Fibrosis Therapeutics Market Dynamics
2.3.1 Cystic Fibrosis Therapeutics Industry Trends
2.3.2 Cystic Fibrosis Therapeutics Market Drivers
2.3.3 Cystic Fibrosis Therapeutics Market Challenges
2.3.4 Cystic Fibrosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue
3.1.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Cystic Fibrosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cystic Fibrosis Therapeutics Revenue
3.4 Global Cystic Fibrosis Therapeutics Market Concentration Ratio
3.4.1 Global Cystic Fibrosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Therapeutics Revenue in 2024
3.5 Global Key Players of Cystic Fibrosis Therapeutics Head office and Area Served
3.6 Global Key Players of Cystic Fibrosis Therapeutics, Product and Application
3.7 Global Key Players of Cystic Fibrosis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cystic Fibrosis Therapeutics Breakdown Data by Type
4.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2026-2031)
5 Cystic Fibrosis Therapeutics Breakdown Data by Application
5.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cystic Fibrosis Therapeutics Market Size (2020-2031)
6.2 North America Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cystic Fibrosis Therapeutics Market Size by Country (2020-2025)
6.4 North America Cystic Fibrosis Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cystic Fibrosis Therapeutics Market Size (2020-2031)
7.2 Europe Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cystic Fibrosis Therapeutics Market Size by Country (2020-2025)
7.4 Europe Cystic Fibrosis Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Cystic Fibrosis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cystic Fibrosis Therapeutics Market Size (2020-2031)
9.2 Latin America Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Details
11.1.2 Vertex Pharmaceuticals Business Overview
11.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Introduction
11.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.1.5 Vertex Pharmaceuticals Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Cystic Fibrosis Therapeutics Introduction
11.3.4 AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.3.5 AbbVie Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Introduction
11.4.4 Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.4.5 Gilead Sciences Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Cystic Fibrosis Therapeutics Introduction
11.5.4 Novartis Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cystic Fibrosis Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Cystic Fibrosis Therapeutics Introduction
11.7.4 Bayer Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.7.5 Bayer Recent Development
11.8 Celtaxsys
11.8.1 Celtaxsys Company Details
11.8.2 Celtaxsys Business Overview
11.8.3 Celtaxsys Cystic Fibrosis Therapeutics Introduction
11.8.4 Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.8.5 Celtaxsys Recent Development
11.9 Pharmaxis
11.9.1 Pharmaxis Company Details
11.9.2 Pharmaxis Business Overview
11.9.3 Pharmaxis Cystic Fibrosis Therapeutics Introduction
11.9.4 Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.9.5 Pharmaxis Recent Development
11.10 ProQR Therapeutics
11.10.1 ProQR Therapeutics Company Details
11.10.2 ProQR Therapeutics Business Overview
11.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Introduction
11.10.4 ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.10.5 ProQR Therapeutics Recent Development
11.11 PTC Therapeutics
11.11.1 PTC Therapeutics Company Details
11.11.2 PTC Therapeutics Business Overview
11.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Introduction
11.11.4 PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.11.5 PTC Therapeutics Recent Development
11.12 Alcresta Therapeutics
11.12.1 Alcresta Therapeutics Company Details
11.12.2 Alcresta Therapeutics Business Overview
11.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Introduction
11.12.4 Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.12.5 Alcresta Therapeutics Recent Development
11.13 Insmed Incorporated
11.13.1 Insmed Incorporated Company Details
11.13.2 Insmed Incorporated Business Overview
11.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Introduction
11.13.4 Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.13.5 Insmed Incorporated Recent Development
11.14 Savara
11.14.1 Savara Company Details
11.14.2 Savara Business Overview
11.14.3 Savara Cystic Fibrosis Therapeutics Introduction
11.14.4 Savara Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.14.5 Savara Recent Development
11.15 Cyclacel Pharmaceuticals
11.15.1 Cyclacel Pharmaceuticals Company Details
11.15.2 Cyclacel Pharmaceuticals Business Overview
11.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Introduction
11.15.4 Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.15.5 Cyclacel Pharmaceuticals Recent Development
11.16 Vectura
11.16.1 Vectura Company Details
11.16.2 Vectura Business Overview
11.16.3 Vectura Cystic Fibrosis Therapeutics Introduction
11.16.4 Vectura Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.16.5 Vectura Recent Development
11.17 Allergan
11.17.1 Allergan Company Details
11.17.2 Allergan Business Overview
11.17.3 Allergan Cystic Fibrosis Therapeutics Introduction
11.17.4 Allergan Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)
11.17.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CFTR
Table 3. Key Players of Mucolytics
Table 4. Key Players of PERT
Table 5. Key Players of Anti-infectives
Table 6. Key Players of Bronchodilators
Table 7. Global Cystic Fibrosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cystic Fibrosis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cystic Fibrosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Cystic Fibrosis Therapeutics Market Share by Region (2020-2025)
Table 11. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Cystic Fibrosis Therapeutics Market Share by Region (2026-2031)
Table 13. Cystic Fibrosis Therapeutics Market Trends
Table 14. Cystic Fibrosis Therapeutics Market Drivers
Table 15. Cystic Fibrosis Therapeutics Market Challenges
Table 16. Cystic Fibrosis Therapeutics Market Restraints
Table 17. Global Cystic Fibrosis Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Cystic Fibrosis Therapeutics Market Share by Players (2020-2025)
Table 19. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2024)
Table 20. Ranking of Global Top Cystic Fibrosis Therapeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Cystic Fibrosis Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Cystic Fibrosis Therapeutics, Headquarters and Area Served
Table 23. Global Key Players of Cystic Fibrosis Therapeutics, Product and Application
Table 24. Global Key Players of Cystic Fibrosis Therapeutics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cystic Fibrosis Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2020-2025)
Table 28. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2026-2031)
Table 30. Global Cystic Fibrosis Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2020-2025)
Table 32. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2026-2031)
Table 34. North America Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Cystic Fibrosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Cystic Fibrosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Cystic Fibrosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Cystic Fibrosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Cystic Fibrosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 49. Vertex Pharmaceuticals Company Details
Table 50. Vertex Pharmaceuticals Business Overview
Table 51. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product
Table 52. Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 53. Vertex Pharmaceuticals Recent Development
Table 54. F. Hoffmann-La Roche Company Details
Table 55. F. Hoffmann-La Roche Business Overview
Table 56. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product
Table 57. F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 58. F. Hoffmann-La Roche Recent Development
Table 59. AbbVie Company Details
Table 60. AbbVie Business Overview
Table 61. AbbVie Cystic Fibrosis Therapeutics Product
Table 62. AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 63. AbbVie Recent Development
Table 64. Gilead Sciences Company Details
Table 65. Gilead Sciences Business Overview
Table 66. Gilead Sciences Cystic Fibrosis Therapeutics Product
Table 67. Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 68. Gilead Sciences Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Cystic Fibrosis Therapeutics Product
Table 72. Novartis Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. AstraZeneca Company Details
Table 75. AstraZeneca Business Overview
Table 76. AstraZeneca Cystic Fibrosis Therapeutics Product
Table 77. AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 78. AstraZeneca Recent Development
Table 79. Bayer Company Details
Table 80. Bayer Business Overview
Table 81. Bayer Cystic Fibrosis Therapeutics Product
Table 82. Bayer Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 83. Bayer Recent Development
Table 84. Celtaxsys Company Details
Table 85. Celtaxsys Business Overview
Table 86. Celtaxsys Cystic Fibrosis Therapeutics Product
Table 87. Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 88. Celtaxsys Recent Development
Table 89. Pharmaxis Company Details
Table 90. Pharmaxis Business Overview
Table 91. Pharmaxis Cystic Fibrosis Therapeutics Product
Table 92. Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 93. Pharmaxis Recent Development
Table 94. ProQR Therapeutics Company Details
Table 95. ProQR Therapeutics Business Overview
Table 96. ProQR Therapeutics Cystic Fibrosis Therapeutics Product
Table 97. ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 98. ProQR Therapeutics Recent Development
Table 99. PTC Therapeutics Company Details
Table 100. PTC Therapeutics Business Overview
Table 101. PTC Therapeutics Cystic Fibrosis Therapeutics Product
Table 102. PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 103. PTC Therapeutics Recent Development
Table 104. Alcresta Therapeutics Company Details
Table 105. Alcresta Therapeutics Business Overview
Table 106. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product
Table 107. Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 108. Alcresta Therapeutics Recent Development
Table 109. Insmed Incorporated Company Details
Table 110. Insmed Incorporated Business Overview
Table 111. Insmed Incorporated Cystic Fibrosis Therapeutics Product
Table 112. Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 113. Insmed Incorporated Recent Development
Table 114. Savara Company Details
Table 115. Savara Business Overview
Table 116. Savara Cystic Fibrosis Therapeutics Product
Table 117. Savara Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 118. Savara Recent Development
Table 119. Cyclacel Pharmaceuticals Company Details
Table 120. Cyclacel Pharmaceuticals Business Overview
Table 121. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product
Table 122. Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 123. Cyclacel Pharmaceuticals Recent Development
Table 124. Vectura Company Details
Table 125. Vectura Business Overview
Table 126. Vectura Cystic Fibrosis Therapeutics Product
Table 127. Vectura Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 128. Vectura Recent Development
Table 129. Allergan Company Details
Table 130. Allergan Business Overview
Table 131. Allergan Cystic Fibrosis Therapeutics Product
Table 132. Allergan Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)
Table 133. Allergan Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 137. Authors List of This Report


List of Figures
Figure 1. Cystic Fibrosis Therapeutics Picture
Figure 2. Global Cystic Fibrosis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cystic Fibrosis Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. CFTR Features
Figure 5. Mucolytics Features
Figure 6. PERT Features
Figure 7. Anti-infectives Features
Figure 8. Bronchodilators Features
Figure 9. Global Cystic Fibrosis Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Cystic Fibrosis Therapeutics Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Cystic Fibrosis Therapeutics Report Years Considered
Figure 14. Global Cystic Fibrosis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Cystic Fibrosis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Cystic Fibrosis Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global Cystic Fibrosis Therapeutics Market Share by Players in 2024
Figure 18. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Cystic Fibrosis Therapeutics Revenue in 2024
Figure 20. North America Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Cystic Fibrosis Therapeutics Market Share by Country (2020-2031)
Figure 22. United States Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cystic Fibrosis Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cystic Fibrosis Therapeutics Market Share by Region (2020-2031)
Figure 34. China Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cystic Fibrosis Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cystic Fibrosis Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 51. AbbVie Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 52. Gilead Sciences Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 54. AstraZeneca Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 55. Bayer Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 56. Celtaxsys Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 57. Pharmaxis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 58. ProQR Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 59. PTC Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 60. Alcresta Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 61. Insmed Incorporated Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 62. Savara Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 63. Cyclacel Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 64. Vectura Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 65. Allergan Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies